"Good news"....so what constitutes good news. IMO

"Good news"....so what constitutes good news. IMO, good news for the company is not another indication or progress in the studies that I consider to be a current distraction. If you want to address NASH, GvHD, MS, or try to convince me we are at an inflection point, save it. I'm expecting a steady stream of comments about how all of these are now part of what we are targeting. Throw in a couple of non-binding term sheets and some potential licensing discussions, and you have the same thing that has gotten us nowhere in 2019.

Good news to me will be signed binding agreements for non-dilutive financing/ partnerships with upfront payments, or real progress on the BLA or mono trials that get us to commercialization in 2020. EVERYTHING else that is typically mentioned lately is a distraction.

I hope to get back from vacation next Saturday and see this stuck to the top of the board with everyone taking shots at me for being so wrong after the meeting/webcast. Good luck to the longs here.